Bought Fresenius yesterday at noon before the figures, had hoped for strong figures and unfortunately went in a day too early to lower my investment. I believe in the management around Michael Sen and am positive about the future. In the meantime, the share has also turned positive again 💪

15 increases

13 unchanged

7 reductions

Insurance companies

Banks

Utilities

Car stocks

Type here if you like collecting dividends: https://shorturl.at/83W8R

$MBG (-0,23%)
$ALV (+1,17%)
$VOW3 (-1,31%)
$MUV2 (-1,18%)
$BMW (-0,6%)
$AIR (-0,38%)
$CBK (-0,13%)
$523232
$DTG (+0,41%)
$DHL (+0,07%)
$FME (-1,37%)
$FRE (-2,59%)
$HNR1 (+0%)
$MTX (-1,53%)
$RHM (-2,11%)
$SAP (-1,19%)
$ENR (+1,68%)
$BAS (+1,29%)
$BAYN (-0,39%)
$BEI (-1,67%)
$DBK (-0,39%)
$DTE (+1,39%)
$EOAN (+3,29%)
$GEA
$IFX (+4,07%)
$RWE (+0,05%)
$SY1 (-0,7%)
$ZAL (-0,59%)
$ADS (-0,33%)
$BNR (-0,4%)
$HEN (-0,59%)
$MRK (+0,23%)
$SIE (-0,59%)
$SHL (-0,21%)

$FRE (-2,59%) presented its quarterly figures for the fourth quarter and the full year 2025 today.

• Turnover (expected): 5.86 billion euros
• Turnover (reported): EUR 5.9 billion

• EPS (expected): EUR 0.91
• EPS (reported): 0.78 euros

The operating cash flow also increased significantly.

Forecast for 2026 $FRE (-2,59%) organic sales growth of 4 - 7% and core EPS growth of 5 - 10%. These are solid but comparatively moderate targets. Analysts were somewhat disappointed after the publication. The somewhat subdued outlook is primarily due to the continuing macroeconomic and regulatory uncertainties.

$FRE (-2,59%) has, in my opinion, closed the year 2025 strongly. Significant sales and EPS growth was achieved. Cash flow also improved and a higher dividend was announced. For me, these developments indicate a successful implementation of the turnaround. At the same time, the cautious outlook for 2026 shows that the management is deliberately setting realistic and not excessive targets.

How do you classify the outlook for 2026? Is this a reasonable safeguard on the part of the management?

https://de.investing.com/news/company-news/fresenius-q4-2025-organisches-wachstum-von-9--kront-erfolgreiches-transformationsjahrn-93CH-3360267

~ No investment advice ~

Tomorrow it will $FRE (-2,59%) will publish its figures for the past quarter tomorrow. Analysts and investors will be focusing primarily on sales and earnings per share, as both key figures should show whether the ongoing restructuring and turnaround process is bearing fruit. According to current consensus data, the market expects:

Sales (expected): EUR 5.86bn

EPS (expected): EUR 0.91

What I will pay particular attention to:

• Operational stability: $FRE (-2,59%) operates in several segments (Kabi, Helios, Vamed, etc.), which offers diversification on the one hand, but also shows that individual areas perform differently. The focus is therefore on organic sales growth and improved margins, particularly in the clinical business.
• Cost management & efficiency: In recent years, the company has implemented structural programmes and portfolio adjustments, among other things, in order to increase profitability and stabilize earnings. Accordingly, I will pay attention to how these measures are working in the current quarter.
• Cash flow & balance sheet: Especially in a capital-intensive healthcare environment, the development of free cash flow and debt remains an issue, as these have an impact on investments and the ability to pay dividends.

An additional strategic signal comes from the early extension of CEO Michael Sen's contract until 2031, which is attracting attention today. This personnel decision can be seen as a signal of continuity and confidence in the ongoing restructuring and growth course, especially at a time when many stakeholders are looking for clear management decisions.

How do you assess the current upheaval at $FRE (-2,59%) ? Do you believe that the measures taken in the current quarter will lead to clear progress, or are some risks not yet sufficiently priced in?

https://de.investing.com/news/stock-market-news/kreise-fresenius-verlangert-vertrag-von-konzernchef-sen-vorzeitig-bis-2031-3357744

~ No investment advice ~

These companies from my portfolio will be reporting in the coming days:

• $O (+0,14%)
• 
  $FRE (-2,59%)
• 
  $ALV (+1,17%)
• 
  $DTE (+1,39%)
• 
  $BAS (+1,29%)

Most interesting figures for my portfolio this week - $BAS (+1,29%)

For me, the $BAS (+1,29%) -figures are the most exciting. The big question: are we finally seeing a cyclical recovery - or will the pressure on margins persist?

The chemical sector is a classic early indicator for the industry. If demand, incoming orders or margins show the first signs of stabilization, this could be a signal for a broader economic recovery. Precisely because $BAS (+1,29%) continues to be one of the leading chemical companies in Germany, the figures are a particular priority for me.

If, on the other hand, the environment remains weak, the patience of us investors is likely to be further tested.

Of course $ALV (+1,17%) , $DTE (+1,39%) & Co. also provide important insights, but $BAS (+1,29%) is about the larger macroeconomic perspective. The overarching question remains: is the cycle turning - yes or no?

Which quarterly figures do you find most exciting this week - and why?

$DPZ (+1,13%)
$HIMS (+2,14%)
$KTOS (+1,47%)
$DOCN (+0,62%)
$FME (-1,37%)
$KDP (+0,67%)
$AMT (+0,43%)
$HD (+0,27%)
$WDAY (+0,09%)
$FSLR (+2,63%)
$TEM (+1,35%)
$O (+0,14%)
$MELI (+1,03%)
$HPQ (+0,91%)
$LCID (+2,16%)
$DRO (+2,6%)
$HSBA (+0,57%)
$FRE (-2,59%)
$AG1 (-1,06%)
$CRCL (+2,21%)
$UTHR (+1,1%)
$LDO (+0,19%)
$IDR (-2,09%)
$NTNX (+1,28%)
$PARA (+0,21%)
$NVDA (+2,79%)
$TTD (+0,64%)
$AI (+1,07%)
$CRM (+0,25%)
$SNPS (+0,81%)
$SNOW (+0,62%)
$PSTG (+3,63%)
$ZIP (+0,16%)
$ZM (+1,54%)
$NU (+0,95%)
$RR. (+0,91%)
$MUV2 (-1,18%)
$BIDU (+0,08%)
$CELH
$DTE (+1,39%)
$STLAM (-0,67%)
$WBD (+0,24%)
$HAG (+1,01%)
$QBTS (+2,36%)
$LKNCY (-0,18%)
$BABA (+0,78%)
$G24 (+2,67%)
$HTZ (+1,12%)
$PUM (-1,21%)
$AIXA (+6,62%)
$RUN (+0,58%)
$INTU (-0,16%)
$WULF (+2,02%)
$MNST (+0,49%)
$SQ (-0,2%)
$ADSK (+0,8%)
$MP (+1,26%)
$RKLB (+6,4%)
$SOUN
$SMR
$CRWV (+2,69%)
$CPNG (+0,15%)
$DUOL

It's interesting how the distribution has shifted...

$FRE (-2,59%) , $INOD (+7,93%) , $BT.A (+1,89%) and $HIMS (+2,14%) no longer in the portfolio...

The sensible use of saved capital in retirement requires good planning. Especially if you want money to flow out of it regularly to secure or sweeten the third stage of your life.

Financial brokers then like to offer pension insurance based on a single payment, often called an immediate annuity.

With a normal life expectancy, the return is usually not generous because insurers usually invest very conservatively. In addition, the costs and profit margins of the insurance company further reduce the return. Consumer advocates point out that you usually have to live to be 94 years or older before you receive the investment sum back via guaranteed pensions.

It is often more profitable to park the money in a call money account.

Investments with regular distributions are an alternative. Investors are spoiled for choice between several thousand dividend-paying equity funds.

What are the relevant selection criteria? Quality and cost structure.

For some, the level of distributions may also be an important criterion in the selection process. But caution is advised here: For example, the payout ratio of the Global X Super Dividend ETF $SDIP (-1,22%) is currently over nine percent. With an investment sum of 100,000 euros, this results in a monthly inflow of around 750 euros before tax.

This is possible because the ETF invests stubbornly in the 100 companies with the highest dividends worldwide, but without any consideration of the sustainability of these distributions and the quality of the companies.

This in turn means that, without the dividends, the ETF generated a return of zero over one year and even minus 14% over three years. Investors therefore received high regular payouts, but the investment capital decreased significantly at the same time.

Savers should therefore always pay attention to how the ETF invests. There are various positive counter-examples, such as the Invesco Euro Stoxx High Dividend Low Volatility ETF $EUHD (-0,52%). Although this also focuses on high-dividend companies, it also selects according to qualitative criteria. Result: Although the payout ratio is currently "only" 5.1% per year, this amounts to around EUR 425 per month before tax for an investment sum of EUR 100,000.

However, the ETF has also achieved growth of almost 36% over the past three years, and including distributions, the gain was even over 60%. There are similarly good ETFs for various other investment regions or sectors.

Bond ETFs, on the other hand, are rarely a real alternative for private investors. Although distribution rates of four or five percent can be achieved, this is ultimately only possible with high-risk bonds or US securities with a corresponding currency risk. In addition, a positive return can rarely be achieved over and above the distribution.

A (possibly riskier) alternative is to invest in individual shares with high dividends. However, quality is even more important here. "We value companies with a strong balance sheet that are characterized by a high equity ratio and above-average returns on capital and sales," says Franz Kaim from Kidron Vermögensverwaltung in Stuttgart.

Continuity is also important. "The so-called dividend aristocrats are the gold standard for income-oriented investors," says Rainer Laborenz, Managing Partner of Azemos Vermögensverwaltung in Offenburg. "Companies that have increased their dividends for at least 25 consecutive years are included in this select group."

There are currently around 150 dividend aristocrats worldwide, 117 of which are from the USA and 33 from the rest of the world. The best-known names include Coca-Cola $KO (+0,14%)Procter & Gamble $PG (+0,02%) and Johnson & Johnson $JNJ (-0,32%) from the USA, Fresenius from Germany $FRE (-2,59%) and Unilever $ULVR (-0,3%) from Great Britain.

Other attractive dividend stocks recommended in a WELT survey of ten leading asset managers in Germany include Allianz $ALV (+1,17%)BASF $BAS (+1,29%)Beiersdorf $BEI (-1,67%)Deutsche Post $DHL (+0,07%) and Munich Re $MUV2 (-1,18%).

In other European countries, they rely on BAT $BATS (+1,39%), BP $BP. (+1,15%), Nestlé $NESN (-1,12%), NN Group $NN (-0,31%)Shell $SHEL (+0,32%) and Swiss Life $SLHN (-0,11%).

In the USA, names such as Altria $MO (-0,37%), Chevron $CVX (-0,03%)Cisco $CSCO (-0,12%), Coca-Cola, Kimberly-Clark $KMB (-0,01%) , McDonald's $MCD (+0,32%) or Pepsi $PEP (-0,11%).

Source: Text (excerpt) & table: Welt, 05.12.25

$BNTX (+0,06%)
$ON (+3,1%)
$HIMS (+2,14%)
$PLTR (-1,3%)
$O (+0,14%)
$8058 (+6,4%)
$7974 (-0,61%)
$BP. (+1,15%)
$BOSS (-1,55%)
$SWK (+0,55%)
$SPOT (+0,75%)
$N1CL34
$UBER (+0,26%)
$CPRI (-0,82%)
$SHOP (+1,32%)
$RACE (-1,38%)
$HOG (+0,05%)
$HTZ (+1,12%)
$PFIZER
$UPST (+1%)
$ANET (+2,04%)
$PINS (-0,85%)
$TEM (+1,35%)
$AMD (+2,93%)
$SMCI (+2,44%)
$RIVN (+0,74%)
$BYND (-0,34%)
$KTOS (+1,47%)
$CPNG (+0,15%)
$BMW (-0,6%)
$NOVO B (+1,81%)
$FRE (-2,59%)
$ORSTED (+0,64%)
$AG1 (-1,06%)
$EVT (-4,94%)
$CCO (+0,54%)
$DOCN (+0,62%)
$LMND (+1,36%)
$SONO (+0,1%)
$MCD (+0,32%)
$HOOD (+1,47%)
$QCOM (+5,63%)
$FTNT (+0,76%)
$FSLY (+1,89%)
$HUBS (+0,16%)
$ELF (+1,09%)
$ARM (+2,38%)
$SNAP (+0,74%)
$DASH (+0,48%)
$APP (+0,65%)
$AMC (+0,83%)
$ZIP (+0,16%)
$FIG (+0,91%)
$LCID (+2,16%)
$DUOL
$UN0 (+0,75%)
$CBK (-0,13%)
$DEZ (-1,21%)
$ZAL (-0,59%)
$HEN (-0,59%)
$MAERSK A (+1,5%)
$HEI (-0,98%)
$CON (-0,67%)
$AZN (+1,29%)
$ALB (-0,9%)
$MRNA (+0,7%)
$QBTS (+2,36%)
$WBD (+0,24%)
$LI (+0%)
$RHM (-2,11%)
$DDOG (+0,83%)
$RL (-0,1%)
$OPEN (+1,55%)
$ABNB (+0,01%)
$PTON (+1,97%)
$MP (+1,26%)
$TTD (+0,64%)
$STNE (+0,74%)
$SQ (-0,2%)
$GRND (+0,84%)
$IREN (+1,49%)
$AFRM (+1,28%)
$CRISP (+0,01%)
$RUN (+0,58%)
$7011 (+1,63%)
$DTG (+0,41%)
$HAG (+1,01%)
$DKNG (+0,48%)
$LAC (+2,32%)
$KKR (+0,56%)
$PETR3 (-0,32%)
$CEG
$WEED (+1,29%)

This consists of dividend shareswhose distributions are automatically reinvested.

In addition to my ETFs (MSCI World, Nasdaq), I would like to use this approach a little more return deliberately with slightly higher risk.

Diversification is the key for me: ETFs for the broad base, dividends for the extra boost.

$MAIN (+0,97%)

$BRK.B (-0,07%)

$MSFT (+0,15%)

$GOOGL (+0,56%)

$RKLB (+6,4%)

$FRE (-2,59%)

$HIMS (+2,14%)

$NOVO B (+1,81%)

$RR. (+0,91%)

$MC (-1,59%)